Related Experiment Video
Updated: Aug 15, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Sero-epidemiology of hepatitis A in black South African children
S S Abdool Karim1, A Coutsoudis
1Centre for Epidemiological Research in Southern Africa, South African Medical Research Council (Natal), Durban.
Insights
Hepatitis A virus (HAV) infection is highly prevalent in urban South African children by age 2. Infant vaccination could significantly reduce HAV spread, but more research is needed on maternal antibodies and vaccine effectiveness in infants.
Area of Science:
- Epidemiology
- Virology
- Public Health
Background:
- Hepatitis A virus (HAV) infection poses a significant public health challenge globally.
- Understanding age-specific prevalence is crucial for effective intervention strategies.
Purpose of the Study:
- To determine the age-specific prevalence of Hepatitis A virus (HAV) infection in urban black children in South Africa.
- To inform potential infant vaccination strategies for HAV.
Main Methods:
- A community-based sero-epidemiological survey was conducted.
- 782 urban black children aged 0-13 years were sampled.
- Prevalence of anti-HAV antibodies was measured.
Main Results:
- Prevalence of anti-HAV antibodies was 68.8% in infants 0-5 months, decreasing to 2.5% at 6-11 months due to maternal antibodies.
- By age 2, prevalence reached 51.2%, rising to 81.4% by age 4 and nearly 100% by age 6.
- Poor socio-economic and environmental conditions correlate with high HAV prevalence.
Conclusions:
- Infant vaccination against HAV is likely to have the greatest impact on disease spread.
- Further research is required on vaccine immunogenicity in infants and the interference of maternal antibodies before widespread infant vaccination can be recommended.
Abstract:
A community-based sero-epidemiological survey was undertaken to determine the age-specific prevalence rates of hepatitis A virus (HAV) infection in a representative sample of 782 urban black children aged from newborn to 13 years. Among children aged 0-5 months, the prevalence of anti-HAV was 68.8% (95% confidence interval (CI) 60.6-77.0%); this fell to a low of 2.5% (CI 0.1-4.9%) in those aged 6-11 months, implying the presence of maternal antibody in the first few months of life. By the age of 2 years, 51.2% (CI 45.7-56.7%) had anti-HAV, by age 4 the prevalence had risen to 81.4% (CI 75.5-87.3%) and by age 6, the prevalence of anti-HAV was almost 100% (CI 90.5-96.7%), reflecting the poor socio-economic and environmental conditions these children live in. The lowest prevalence of HAV infection among urban black South African children was during infancy, before the age at which the incidence rate rose sharply; e.g. 1 out of 5 children was already infected with HAV by its 2nd birthday. Vaccination in infancy will therefore have the biggest impact on the spread of HAV. However, before HAV vaccination in infancy is advocated, vaccine immunogenicity in infancy and the possible detrimental effect of maternal antibodies on the immunogenicity of the vaccine need clarification.
Related Concept Videos
Yellow Fever
Hepatitis
Amebiasis
Viral Hepatitis I: Introduction

